Compare Eli Lilly And Co (LLY) vs Invesco S&P 500 Momentum ETF (SPMO) Price & Performance

Eli Lilly And CoTrade

Invesco S&P 500 Momentum ETFTrade

Price performance (Past 24H)

Key statistics

Eli Lilly And Co vs Invesco S&P 500 Momentum ETF — how do they compare? Eli Lilly And Co trades at $1,174 (market cap $1.02T), while Invesco S&P 500 Momentum ETF trades at $150. The key difference: Eli Lilly And Co pays a 0.6% dividend while Invesco S&P 500 Momentum ETF pays none. Which is the better fit depends on your goals.

	LLY	SPMO
Market Cap	$1.02T	—
Sector	Health	Broad Market / Factor
52-Week High	$1.24K	$161.66
52-Week Low	$625.65	$107.84
Enterprise Value	$1.06T	—
Dividend Yield	0.6%	—

View details →View details →

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Eli Lilly And Co

No Aura AI signal available yet.

Invesco S&P 500 Momentum ETF

SPMO trades at $144.50 with a slight 0.42% daily gain. Technical indicators show a bearish trend with moving averages signaling caution, though oscillators are neutral. Recent news highlights strong momentum performance, with the ETF gaining 7.5% in June 2026 and leading S&P factors. The portfolio is concentrated in technology stocks, benefiting from AI-driven growth but facing volatility risks.

Outlook remains mixed; AI momentum supports growth, but high concentration and bearish technicals pose risks. Investors should weigh the ETF's rules-based strategy against potential sector rotations. Dividend of $0.25 is scheduled for June 2026, adding income appeal amid market uncertainty.

Aura AI is an analytical signal, not financial advice — do your own research.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

LLY

Over 180 companies develop 200+ PD-1/PD-L1 inhibitors, reshaping cancer treatment landscape.Delveinsight · 4 hours agoBullish Novo Nordisk sues Eli Lilly over misleading GLP-1 drug ads claiming superior weight-loss results.Proactive Investors · 9 hours agoBearish Novo Nordisk sues Eli Lilly over misleading ads on obesity and diabetes drug efficacy.CNBC · 13 hours agoBearish View details →

SPMO

View details →

About Eli Lilly And Co

Eli Lilly is a drug firm with a focus on neuroscience, endocrinology, cancer, and immunology. Lilly's key products include Verzenio for cancer

About Invesco S&P 500 Momentum ETF

SPMO is designed to track the investment results of the S&P 500 Momentum Index. This index measures the performance of stocks in the S&P 500 that exhibit the highest momentum, or the greatest price appreciation, over the trailing 12 months, while excluding the most recent month. By investing in these high-momentum stocks, SPMO seeks to capitalize on the historical trend that stocks with strong recent performance tend to continue that performance in the near term, offering a systematic approach to factor investing within the large-cap U.S. equity market.